These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8266011)

  • 21. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites.
    Alam I; Bass NM; Bacchetti P; Gee L; Rockey DC
    Am J Gastroenterol; 2000 Jan; 95(1):199-203. PubMed ID: 10638583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tissue polypeptide antigen and carcinoembryonic antigen in bladder neoplasms].
    Krajewska B; Stelmach W; Lutz W; Matych J
    Med Pr; 1995; 46(1):7-16. PubMed ID: 9732842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Matsushima M; Kuwabara T; Miyamae K; Hachiya A; Kawahara M; Fukasawa K; Yagishita T; Tajima M; Sawamura Y; Shirai M
    Hinyokika Kiyo; 1984 Jul; 30(7):869-75. PubMed ID: 6507205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttila I
    Anticancer Res; 1993; 13(5C):1883-7. PubMed ID: 8267397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased serum tissue polypeptide specific antigen (TPS) in alcoholics: a possible marker of alcoholic hepatitis.
    González-Quintela A; Mella C; Pérez LF; Abdulkader I; Caparrini AM; Lojo S
    Alcohol Clin Exp Res; 2000 Aug; 24(8):1222-6. PubMed ID: 10968661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Measurement of serum tissue-polypeptide antigen (TPA) levels by EIA employing monoclonal antibody].
    Takami H
    Gan To Kagaku Ryoho; 1994 May; 21(6):853-8. PubMed ID: 8185344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative tumor markers as prognostic factors of colorectal liver metastases.
    Treska V; Topolcan O; Stanislav K; Liska V; Holubec L
    Hepatogastroenterology; 2009; 56(90):317-20. PubMed ID: 19579590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Anticancer Res; 1995; 15(6B):2731-7. PubMed ID: 8669855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring of therapy in inoperable lung cancer patients by measurement of CYFRA 21-1, TPA- TP CEA, and NSE.
    Ebert W; Hoppe M; Muley T; Drings P
    Anticancer Res; 1997; 17(4B):2875-8. PubMed ID: 9329552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
    Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
    J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of tissue polypeptide antigen as a marker in bladder cancer].
    Menéndez V; Filella X; Alcover J; Molina R; Ballesta AM; Carretero P
    Actas Urol Esp; 1995 Jun; 19(6):441-4. PubMed ID: 8571803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships among serum iron status markers, chemical and histochemical liver iron content in 117 patients with alcoholic and non-alcoholic hepatic disease.
    Milman N; Graudal N; Hegnhøj J; Christoffersen P; Pedersen NS
    Hepatogastroenterology; 1994 Feb; 41(1):20-4. PubMed ID: 8175108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor markers as useful predictors of survival rate after exploratory laparotomy for liver malignancies.
    Liska V; Holubec L; Treska V; Skalicky T; Sutnar A; Topolcan O; Kormunda S; Finek J
    Anticancer Res; 2007; 27(4A):1887-91. PubMed ID: 17649789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serum laminin in chronic alcoholic liver disease: its value in the estimation of the degree of fibrosis].
    González Reimers E; Santolaria Fernández F; Rodríguez Rodríguez E; Rodríguez Moreno F; Milena Abril A; Martínez-Riera A; García-Castro C
    Rev Esp Enferm Dig; 1996 Apr; 88(4):241-5. PubMed ID: 9004793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue polypeptide antigen in bronchogenic carcinoma.
    Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
    Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential tumor markers and hepatitis markers profile in liver tumors.
    Khalifa A; Mady EA; Abadeer N; Kamal A
    Anticancer Res; 1999; 19(4A):2495-500. PubMed ID: 10470181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative evaluation of four tumor markers, CA 242, CA 19/9, TPA and CEA in carcinomas of the colon.
    von Kleist S; Hesse Y; Kananeeh H
    Anticancer Res; 1996; 16(4B):2325-31. PubMed ID: 8694564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum tumor markers in chronic liver disease.
    Kadayifci A; Simsek H; Savas MC; Toppare M
    Neoplasma; 1996; 43(1):17-21. PubMed ID: 8843954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Four tumour markers for urinary bladder cancer--tissue polypeptide antigen (TPA), HER-2/neu (ERB B2), urokinase-type plasminogen activator receptor (uPAR) and TP53 mutation.
    Ecke TH; Schlechte HH; Schulze G; Lenk SV; Loening SA
    Anticancer Res; 2005; 25(1B):635-41. PubMed ID: 15816639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.